We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Gilead Sciences announced second-quarter results Wednesday showing that the company's net income was $3.1 billion, compared to $3.5 billion for the corresponding 2016 period.